GlassScriptPhysician profile
Stephanie A Stegall
NPI 1578538013
$2,382.33
in general payments reported to CMS, 2019-2025
22 companies · $594 in 2025
The $594 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $145 · 2021: $301 · 2022: $117 · 2023: $515 · 2024: $549 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $477.49 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $461.82 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $365.88 | 2019-2024 | Jornay Pm |
| Novo Nordisk INC | $205.75 | 2023-2024 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $134.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $112.20 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Collegium Pharmaceutical, INC. | $107.01 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $103.50 | 2019-2025 | |
| Pfizer INC. | $73.86 | 2020-2024 | |
| Neos Therapeutics, LP | $68.88 | 2019-2020 | |
| Adlon Therapeutics L.P. | $47.17 | 2021 | |
| Chiesi USA, INC. | $27.18 | 2025 | Filsuvez |
| Kyowa Kirin, INC. | $23.40 | 2025 | |
| Krystal Biotech INC | $22.86 | 2023 | Vyjuvek |
| Tris Pharma INC | $22.15 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $20.95 | 2024 | Relexxii |
| Dermira, INC. | $20.33 | 2020 | |
| Seqirus USA INC | $18.83 | 2021 | |
| Rhodes Pharmaceuticals L.P. | $18.13 | 2019 | |
| Verrica Pharmaceuticals INC. | $18.11 | 2023 | Ycanth |
| Genentech USA, INC. | $17.48 | 2021 | |
| Journey Medical Corporation | $14.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Stegall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.